Obstetrics Gynecology Archives - Carey Danis & Lowe

Mirena IUD: Study Looks at Breast Cancer

By | Mirena, Pharmaceutical litigation, Uncategorized

mirena_iud_birth_control_lawsuit_litigation_bayerA study recently published in the Journal of Obstetrics & Gynecology looked at the incidence of various types of cancer in women using an intrauterine device (IUD) containing the hormone levonorgestrel to treat menorrhagia, a condition involving abnormal bleeding during menstruation. The study involved over 93,000 women, and took place over a 13 year period in Finland.

The study found that the rate of breast cancer in the group of women was higher than expected, with the expected number of women with breast cancer being 1,292, and the actual number of women with breast cancer in the study being 1,542.

Though further research must be conducted before confirming a strong link between the use of intrauterine devices containing levonorgestrel and breast cancer, the study’s results do present important findings.

The Mirena intrauterine device (IUD) contains the hormone levonorgestrel, and has been known for uterine perforation and device migration.

The possibility of the Mirena IUD causing an increased risk of breast cancer is a health issue worth further investigation.

Carey Danis & Lowe Is Here to Help

Carey Danis & Lowe is a St. Louis law firm that represents women who have been injured by the Mirena IUD. If you or someone you love has sustained an injury after using the Mirena IUD, our personal injury lawyers encourage you to begin exploring your legal options today.

Share your Mirena IUD story with Carey Danis & Lowe during a free initial case evaluation. Give us a call at 800.721.2519, or complete one of our confidential personal injury claim forms.


Studies Show Surgery Alleviates Pain of Defective Transvaginal Mesh Victims

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

transvaginal_mesh_lawsuit_settlements_mdl_multidistrict_litigation_class_action_lawsuit_vaginal_mesh_fda_lawsuitsTwo research studies published late last year gathered intriguing data about transvaginal mesh and surgical treatments to mollify patient pain and other side effects. Researchers involved in these two studies found that, following surgical operations, patients continued to suffer from persistent pain, though it was alleviated.

One research study was published in the International Urogynecology Journal in October 2013, and the other article was published in the Obstetrics & Gynecology journal in December 2013.

The study published in the International Urogynecology Journal is titled “Short-term surgical outcomes and characteristics of patients with mesh complications from pelvic organ prolapse and stress urinary incontinence surgery”. Conducted over an eleven year period, the motivation to execute the study was to collect useful information on patient health and well being following surgical operations to repair and remove defective transvaginal mesh.

Researchers involved in the International Urogynecology Journal study found that nearly 56% of participating patients had chronic pelvic pain, with 54% experiencing dyspareunia, and 31% with abnormal vaginal discharge.

In concluding their findings, the researchers stated that, though mesh removal is a useful treatment for patients, the severe pelvic pain and other side effects continue, though somewhat mollified.

Carey Danis & Lowe Can Help You

Carey Danis & Lowe is dedicated to providing expert legal counsel and useful health resources to victims of defective transvaginal mesh. If you believe that you have been injured by transvaginal mesh, attorneys at Carey Danis & Lowe encourage you to explore your legal options with us today. Our initial consultations are free, and our attorneys can assist you with filing a transvaginal mesh lawsuit.

As we are dedicated to providing you with both legal and medical expertise, Carey Danis & Lowe has a team of medical professionals committed to providing you with current patient health and safety information relating to transvaginal mesh. If you have concerns about transvaginal mesh and your health, you are welcome to discuss them with one of our on-staff nurses.

Carey Danis & Lowe is here to listen to your transvaginal mesh story, and provide you with real solutions. Contact us today by calling 800.721.2519, or by submitting a confidential personal injury claim form.

Overview of Kugel Mesh Lawsuits

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Published May 23, 2012 on InjuryBoard

Trans Vaginal & Kugel Mesh Lawsuits: An OverviewOn February 7, 2012, all federal lawsuits concerning transvaginal mesh products were consolidated into one court in the Southern District of West Virginia before Judge Goodwin. Plaintiffs allegedly suffer from injuries from vaginal mesh products made by American Medical Systems, Boston Scientific, Ethicon, and C.R. Bard.

Women implanted with vaginal mesh for the treatment of conditions like pelvic organ prolapse (POP) and stress urinary incontinence (SUI) seek to hold these manufacturers liable for injuries like erosion, bleeding, urinary incontinence, pelvic pain, protrusion of the mesh, infections, and more. On July 13, 2011, the FDA released a safety communication warning health care providers that such complications from transvaginal mesh were not rare, and that multiple surgeries may not always be successful in resolving them.

Vaginal Mesh Products Made Specifically for POP and SUI

Many women, as they age, experience a weakening or stretching of the pelvic muscles and tissues. This is often due to childbirth, menopause, or surgery. These weakened muscles are then no longer able to support pelvic organs like the bladder, urethra, and bowel, allowing these organs to drop (prolapse) or fall into the vaginal wall. Some women suffer no uncomfortable symptoms, but others may experience pressure, pain, urinary incontinence, painful intercourse, and constipation.

Vaginal mesh products created specifically for the repair of POP and SUI appeared on the market in the 1990s. These products were made of surgical mesh, a synthetic polypropylene net-like material, and were used to provide additional support and stabilization for prolapsed organs. The FDA approved the first product specifically designed for SUI in 1996, and the first for POP in 2002. Since then, many new products have come onto the market.

A few years later, however, the FDA began to receive reports of serious side effects associated with transvaginal mesh. Between 2005–2007, they received more than 1,000 such reports, including erosion of the mesh through the vagina, infections, pain, and scarring.

Studies Show High Rates of Complications

In August 2010, researchers published a study in Obstetrics & Gynecology that questioned the value of vaginal mesh for pelvic organ prolapse repairs. In a three-month comparison of women treated with transvaginal mesh and those treated with traditional therapies (that don’t involve mesh), the authors found that at three months, there was a high vaginal mesh erosion rate of 15.6 percent, with no difference in overall cure rates.

In July 2011, the FDA issued their warning after receiving an additional nearly 3,000 reports of vaginal mesh complications between 2008 and 2010. The agency noted that it had conducted a systematic review of the published scientific literature from 1996 and 2011, and concluded that transvaginal POP repair with mesh “does not improve symptomatic results or quality of life over traditional non-mesh repair.” They added they would continue to evaluate study results for SUI surgeries with mesh.

A study appearing in the Journal of Obstetrics and Gynecology Canada the same year stated that until adequate safety and effectiveness evidence becomes available, use of transvaginal mesh devices for prolapse repair should be considered experimental and should be restricted to investigative trials.

Lawsuits Mounting While FDA Asks for More Studies

Submit your claim — as the first bellwether cases prepare for trial, the FDA has asked manufacturers to conduct new safety studies on their products. A Congressional report released in March 2012 also noted that devices like vaginal mesh received FDA approval based on similar devices with problematic safety profiles.